| Literature DB >> 28165233 |
Gianna Allegrone1, Federica Pollastro1, Gianmaria Magagnini2, Orazio Taglialatela-Scafati3, Julia Seegers4, Andreas Koeberle4, Oliver Werz4, Giovanni Appendino1.
Abstract
Canniprene (1), an isoprenylated bibenzyl unique to Cannabis sativa, can be vaporized and therefore potentially inhaled from marijuana. Canniprene (1) potently inhibited the production of inflammatory eicosanoids via the 5-lipoxygenase pathway (IC50 0.4 μM) and also affected the generation of prostaglandins via the cyclooxygenase/microsomal prostaglandin E2 synthase pathway (IC50 10 μM), while the related spiranoid bibenzyls cannabispiranol (2) and cannabispirenone (3) were almost inactive in these bioassays. The concentration of canniprene (1) was investigated in the leaves of 160 strains of C. sativa, showing wide variations, from traces to >0.2%, but no correlation was found between its accumulation and a specific phytocannabinoid profile.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28165233 DOI: 10.1021/acs.jnatprod.6b01126
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050